Makiko Mitsunami

Dr. Makiko Mitsunami

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
Albert Salas-HuetosAlbert Salas-Huetos
Albert Salas-Huetos
MAMariel Arvizu
Mariel Arvizu
LMLidia Mínguez-Alarcón
Lidia Mínguez-Alarcón
MMMakiko Mitsunami
Makiko Mitsunami
JRJordi Ribas-Maynou
Jordi Ribas-Maynou
JCJorge E Chavarro
Jorge E Chavarro

19 August 2023 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
MMMakiko Mitsunami
Makiko Mitsunami
SWSiwen Wang
Siwen Wang
DSDiana C. Soria-Contreras
Diana C. Soria-Contreras
LMLidia Mínguez-Alarcón
Lidia Mínguez-Alarcón
EOEduardo Ortiz-Panozo
Eduardo Ortiz-Panozo
JCJorge E Chavarro
Jorge E Chavarro

30 May 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
TTTakayuki Takahashi
Takayuki Takahashi
MIMegumi Ichimiya
Megumi Ichimiya
MTMisa Tomono
Misa Tomono
RMRio Minoura
Rio Minoura
TKTakahiro Kinoshita
Takahiro Kinoshita
DSDaisuke Shigemi
Daisuke Shigemi
Human papillomavirus (HPV) infection remains a principal cause of cervical cancer worldwide. Although large-scale vaccination efforts have substantially lowered HPV infection rates and precancerous lesions, not all regions have achieved high coverage. In Japan, proactive HPV vaccine recommendations were suspended from 2013 to 2022 due to concerns over alleged adverse events, causing vaccination rates to drop from over 70% to below 1%. This narrative review synthesized research published from 2014 to 2025 in PubMed, Cochrane Library, and Google Scholar, focusing on English-language studies. Inclusion criteria encompassed analyses of HPV vaccine efficacy or safety, policies related to vaccination in Japan or other countries, and investigations into vaccine hesitancy or media influences. Data were categorized into five thematic areas: historical and policy contexts, evidence of vaccine safety and efficacy, societal drivers of hesitancy, communication strategies, and administrative or clinical interventions. Evidence robustly confirms the HPV vaccine’s favorable safety profile, with severe adverse events appearing exceedingly rare. Nonetheless, media sensationalism and limited risk communication in Japan perpetuated mistrust, impeding vaccination uptake. Comparisons with Denmark and Ireland indicate that transparent, interactive risk communication can restore coverage to near-pre-suspension levels. Japan’s recent policy reforms, including reinstating proactive recommendations and catch-up initiatives, have begun to reverse vaccination hesitancy. Sustained policy support, evidence-based messaging, and empathetic engagement with communities are central to rebuilding trust in the HPV vaccine. Lessons from best international practices emphasize the importance of multifaceted interventions, collaborative stakeholder engagement, and transparent risk communication to reduce the burden of HPV-related malignancies.

3 March 2023 in Fertility and Sterility
Verified
Journal Article
Closed access
MMMakiko Mitsunami
Makiko Mitsunami
LMLidia Mínguez-Alarcón
Lidia Mínguez-Alarcón
AFAndrea A. Florio
Andrea A. Florio
SWSiwen Wang
Siwen Wang
JAJill A. Attaman
Jill A. Attaman
JCJorge E Chavarro
Jorge E Chavarro

31 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
AMAna B. Maldonado-Cárceles
Ana B. Maldonado-Cárceles
ISIrene Souter
Irene Souter
MLMing-Chieh Li
Ming-Chieh Li
MMMakiko Mitsunami
Makiko Mitsunami
IDIrene Dimitriadis
Irene Dimitriadis
JCJorge E Chavarro
Jorge E Chavarro
Background/Objectives: The aim of this study was to investigate the association between antioxidant intake and antral follicle count (AFC), a marker of ovarian reserve, in women attending a fertility clinic. Methods: We conducted an observational study with 567 women undergoing infertility evaluation at the Massachusetts General Hospital Fertility Center, who were enrolled in the Environment and Reproductive Health (EARTH) study. Participants filled out the lifestyle and health questionnaires and a validated food frequency questionnaire (FFQ) for assessing habitual dietary intake and underwent a transvaginal ultrasound to measure AFC. Intake of nutrients with direct antioxidant capacity (vitamin A, C, and E and carotenoids) and intake of antioxidant food sources were estimated from the FFQ. Adjusted Poisson regression models were fitted to assess the relationships between antioxidants and AFC while adjusting for potential confounders. Non-linearity was assessed with restricted cubic splines. Results: The median (interquartile range) age and AFC of participants were 35.0 (32.0–38.0) years and 13 (9–18), respectively. Our findings revealed a non-linear association between lycopene intake and AFC. There was a positive linear association with the highest AFC among women consuming approximately 6000 mcg/day of lycopene (p for non-linearity = 0.003). An inverse association was observed between retinol intake, predominantly from dairy foods, and AFC among women aged under 35 years (p-trend < 0.001 and 0.01, respectively). Conclusions: Our findings suggest that lycopene intake might influence the ovarian reserve in fertility patients. The observed inverse association with retinol, if confirmed, may reflect biological mechanisms different from oxidative stress. The underlying mechanisms of these associations remain to be elucidated and warrant further investigation.

6 September 2024 in Diabetologia
Verified
Journal Article
Closed access
PDF file
DSDiana Soria-Contreras
Diana Soria-Contreras
SWSiwen Wang
Siwen Wang
JLJiaxuan Liu
Jiaxuan Liu
RLRebecca B. Lawn
Rebecca B. Lawn
MMMakiko Mitsunami
Makiko Mitsunami
JCJorge E Chavarro
Jorge E Chavarro